Shares of SWEDISH ORPHAN/S (OTCMKTS:SWTUY – Get Free Report) traded down 1.2% on Wednesday . The stock traded as low as $24.38 and last traded at $24.38. 200 shares were traded during mid-day trading, a decline of 88% from the average session volume of 1,665 shares. The stock had previously closed at $24.67.
SWEDISH ORPHAN/S Stock Down 1.2 %
The stock has a fifty day moving average price of $24.38 and a 200-day moving average price of $24.38. The firm has a market cap of $6.64 billion, a price-to-earnings ratio of 48.76, a price-to-earnings-growth ratio of 1.30 and a beta of 1.81.
About SWEDISH ORPHAN/S
Swedish Orphan Biovitrum AB (publ), an integrated biotechnology company, researches, develops, manufactures, and sells pharmaceuticals in the therapeutic areas of haemophilia, inflammation, and genetic and lysosomal diseases. The company offers Elocta to treat haemophilia A; and Alprolix to treat haemophilia B.
See Also
- Five stocks we like better than SWEDISH ORPHAN/S
- What is the NASDAQ Stock Exchange?
- Moderna Shares Spike on H5N1 News—What’s Next for Investors?
- Which Wall Street Analysts are the Most Accurate?
- Nebius Group (NBIS): A Small-Cap Backed by NVIDIA
- Trading Stocks: RSI and Why it’s Useful
- Natural Gas Demand to Surge: Top 3 Stocks and ETFs to Consider
Receive News & Ratings for SWEDISH ORPHAN/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SWEDISH ORPHAN/S and related companies with MarketBeat.com's FREE daily email newsletter.
